Monograph
R01AC02 - Levocabastine |
Propably not porphyrinogenic |
PNP |
Rationale
Low dose, only insignificant systemic and metabolic exposure.
Chemical description
Selective HI-antagonist used in local treatment of allergic rhinitis. Nasal spray, each dose containing 50 µg levocabastine. Recommended dose gives plasma concentrations in the range 2-9 µg/mL. Excreted in unchanged form (70%) and as glucuronide.
IPNet drug reports
Uneventful use reported in 3 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Livocab 
Livostin 
Bilina 
Livostin · Livostin Direct 
Benaliv 
Livostin 
Livostin 
Livostin 
Livostin
© NAPOS 2025